These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 17363508

  • 1. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
    Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, Chen H.
    Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
    Xia YX, Lu L, Wu ZS, Pu LY, Sun BC, Wang XH.
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of glycogen synthase kinase-3beta is sufficient for airway smooth muscle hypertrophy.
    Deng H, Dokshin GA, Lei J, Goldsmith AM, Bitar KN, Fingar DC, Hershenson MB, Bentley JK.
    J Biol Chem; 2008 Apr 11; 283(15):10198-207. PubMed ID: 18252708
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer.
    Liao X, Zhang L, Thrasher JB, Du J, Li B.
    Mol Cancer Ther; 2003 Nov 11; 2(11):1215-22. PubMed ID: 14617795
    [Abstract] [Full Text] [Related]

  • 7. Constitutive activation of glycogen synthase kinase-3beta correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer.
    Cho YJ, Kim JH, Yoon J, Cho SJ, Ko YS, Park JW, Lee HS, Lee HE, Kim WH, Lee BL.
    BMC Gastroenterol; 2010 Aug 12; 10():91. PubMed ID: 20704706
    [Abstract] [Full Text] [Related]

  • 8. Lenticular mitoprotection. Part B: GSK-3β and regulation of mitochondrial permeability transition for lens epithelial cells in atmospheric oxygen.
    Brooks MM, Neelam S, Cammarata PR.
    Mol Vis; 2013 Aug 12; 19():2451-67. PubMed ID: 24319338
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells.
    Takahashi-Yanaga F, Taba Y, Miwa Y, Kubohara Y, Watanabe Y, Hirata M, Morimoto S, Sasaguri T.
    J Biol Chem; 2003 Mar 14; 278(11):9663-70. PubMed ID: 12522140
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro].
    Cao Q, Feng YJ.
    Zhonghua Zhong Liu Za Zhi; 2006 Nov 14; 28(11):804-9. PubMed ID: 17415999
    [Abstract] [Full Text] [Related]

  • 15. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
    Xu G, Li Y, Yoshimoto K, Wu Q, Chen G, Iwata T, Mizusawa N, Wan C, Nie X.
    Toxicol Lett; 2014 Jan 30; 224(3):362-70. PubMed ID: 24231000
    [Abstract] [Full Text] [Related]

  • 16. From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.
    Gaisina IN, Gallier F, Ougolkov AV, Kim KH, Kurome T, Guo S, Holzle D, Luchini DN, Blond SY, Billadeau DD, Kozikowski AP.
    J Med Chem; 2009 Apr 09; 52(7):1853-63. PubMed ID: 19338355
    [Abstract] [Full Text] [Related]

  • 17. Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation.
    Carmichael J, Sugars KL, Bao YP, Rubinsztein DC.
    J Biol Chem; 2002 Sep 13; 277(37):33791-8. PubMed ID: 12097329
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Involvement of glycogen synthase kinase-3beta in palmitate-induced human umbilical vein endothelial cell apoptosis.
    Choi SE, Kang Y, Jang HJ, Shin HC, Kim HE, Kim HS, Kim HJ, Kim DJ, Lee KW.
    J Vasc Res; 2007 Sep 13; 44(5):365-74. PubMed ID: 17483602
    [Abstract] [Full Text] [Related]

  • 20. The effects of GSK-3β blockade on ketamine self-administration and relapse to drug-seeking behavior in rats.
    Huang X, Huang K, Zheng W, Beveridge TJ, Yang S, Li X, Li P, Zhou W, Liu Y.
    Drug Alcohol Depend; 2015 Feb 01; 147():257-65. PubMed ID: 25497591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.